1. Home
  2. APRE vs SQFT Comparison

APRE vs SQFT Comparison

Compare APRE & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • SQFT
  • Stock Information
  • Founded
  • APRE 2006
  • SQFT 1999
  • Country
  • APRE United States
  • SQFT United States
  • Employees
  • APRE N/A
  • SQFT N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • SQFT Real Estate Investment Trusts
  • Sector
  • APRE Health Care
  • SQFT Real Estate
  • Exchange
  • APRE Nasdaq
  • SQFT Nasdaq
  • Market Cap
  • APRE 8.3M
  • SQFT 7.7M
  • IPO Year
  • APRE 2019
  • SQFT 2020
  • Fundamental
  • Price
  • APRE $1.51
  • SQFT $6.07
  • Analyst Decision
  • APRE Strong Buy
  • SQFT
  • Analyst Count
  • APRE 1
  • SQFT 0
  • Target Price
  • APRE $20.00
  • SQFT N/A
  • AVG Volume (30 Days)
  • APRE 50.3K
  • SQFT 990.4K
  • Earning Date
  • APRE 11-06-2025
  • SQFT 11-11-2025
  • Dividend Yield
  • APRE N/A
  • SQFT N/A
  • EPS Growth
  • APRE N/A
  • SQFT N/A
  • EPS
  • APRE N/A
  • SQFT N/A
  • Revenue
  • APRE $841,012.00
  • SQFT $18,052,597.00
  • Revenue This Year
  • APRE N/A
  • SQFT $23.63
  • Revenue Next Year
  • APRE N/A
  • SQFT N/A
  • P/E Ratio
  • APRE N/A
  • SQFT N/A
  • Revenue Growth
  • APRE N/A
  • SQFT N/A
  • 52 Week Low
  • APRE $1.37
  • SQFT $4.19
  • 52 Week High
  • APRE $5.01
  • SQFT $23.00
  • Technical
  • Relative Strength Index (RSI)
  • APRE 51.04
  • SQFT 54.31
  • Support Level
  • APRE $1.40
  • SQFT $5.46
  • Resistance Level
  • APRE $1.53
  • SQFT $6.22
  • Average True Range (ATR)
  • APRE 0.08
  • SQFT 0.47
  • MACD
  • APRE 0.01
  • SQFT -0.01
  • Stochastic Oscillator
  • APRE 67.77
  • SQFT 58.18

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: